Chen Yuanhan, Cai Lu, Du Zhiming, Xu Jiaqi, Tan Ning, Ye Zhiming, Liu Shuangxin, Dong Wei, Shi Wei, Liang Xinling
Divisionof Nephrology, Guangdong General Hospital, Guangdong Academic of Medical Sciences, Guangzhou, 510080, China.
Department of Cardiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.
Int J Cardiol. 2017 Mar 1;230:59-63. doi: 10.1016/j.ijcard.2016.12.096. Epub 2016 Dec 21.
Proteinuria is common in patients with acute heart failure (AHF). This study investigated the relationship between proteinuria and short-term mortality among patients hospitalized for AHF at two university hospitals.
Adult hospitalized patients with AHF were retrospectively studied. Proteinuria was defined based on the first urine dipstick test within 48 h after the AHF diagnosis. The death risk was assessed using an Enhanced Feedback for Effective Cardiac Treatment (EFFECT) 30-day mortality risk score.
Of the 1,058 eligible patients with AHF, 583 (55.1%) exhibited proteinuria. The degree of proteinuria was positively correlated with poor AHF prognostic indicators (C-reactive protein and N-terminal pro-brain natriuretic peptide) and negatively correlated with protective indicators (basal estimated glomerular filtration rate, haemoglobin, and serum albumin). The EFFECT mortality risk score and the in-hospital mortality rate of patients with proteinuria were significantly higher than that of the patients without proteinuria. According to different multivariate logistic regression models, proteinuria increased the risk of in-hospital mortality after correcting for multiple variables, including the EFFECT mortality risk score, diabetes, RASI, NT-proBNP, albumin and chronic kidney disease stages. Compared with the NT-proBNP, proteinuria and degree of proteinuria yielded higher areas under the ROC curve for predicting in-hospital mortality.
Our results demonstrate that proteinuria correlates with the short-term mortality rate of patients hospitalized for AHF. Dipstick proteinuria testing might represent a promising prognostic indicator for these patients.
蛋白尿在急性心力衰竭(AHF)患者中很常见。本研究调查了两家大学医院因AHF住院的患者中蛋白尿与短期死亡率之间的关系。
对成年AHF住院患者进行回顾性研究。蛋白尿根据AHF诊断后48小时内的首次尿试纸检测来定义。使用强化心脏治疗有效反馈(EFFECT)30天死亡风险评分评估死亡风险。
在1058例符合条件的AHF患者中,583例(55.1%)出现蛋白尿。蛋白尿程度与AHF不良预后指标(C反应蛋白和N末端脑钠肽前体)呈正相关,与保护指标(基础估计肾小球滤过率、血红蛋白和血清白蛋白)呈负相关。蛋白尿患者的EFFECT死亡风险评分和住院死亡率显著高于无蛋白尿患者。根据不同的多变量逻辑回归模型,在校正包括EFFECT死亡风险评分、糖尿病、RASI、NT-proBNP、白蛋白和慢性肾脏病分期等多个变量后,蛋白尿增加了住院死亡风险。与NT-proBNP相比,蛋白尿和蛋白尿程度在预测住院死亡率方面的ROC曲线下面积更高。
我们的结果表明,蛋白尿与因AHF住院患者的短期死亡率相关。尿试纸蛋白尿检测可能是这些患者有前景的预后指标。